Key features and details
- PerCP/Cy5.5® Rat monoclonal [D7] to Sca1 / Ly6A/E
- Suitable for: Flow Cyt
- Reacts with: Mouse
- Conjugation: PerCP/Cy5.5®. Ex: 482nm, Em: 690nm
- Isotype: IgG2a
Product namePerCP/Cy5.5® Anti-Sca1 / Ly6A/E antibody [D7]
See all Sca1 / Ly6A/E primary antibodies
DescriptionPerCP/Cy5.5® Rat monoclonal [D7] to Sca1 / Ly6A/E
ConjugationPerCP/Cy5.5®. Ex: 482nm, Em: 690nm
Tested applicationsSuitable for: Flow Cytmore details
Species reactivityReacts with: Mouse
IL2 dependent T cell line CTL-L (Mouse).
- C57Bl/6 Mouse splenocytes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Storage instructionsShipped at 4°C. Store at +4°C.
Storage bufferpH: 7.20
Preservative: 0.09% Sodium azide
Constituents: 0.87% Sodium chloride, 0.1% Gelatin, PBS
Concentration information loading...
PurityProtein G purified
Light chain typekappa
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab93538 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Tissue specificityWidely expressed.
Sequence similaritiesContains 1 UPAR/Ly6 domain.
modificationsO-glycosylated. Not N-glycosylated.
Cellular localizationCell membrane.
- Information by UniProt
- Ly-6A.2/Ly-6E. antibody
- Ly-6A.2/Ly-6E.1 antibody
- Ly6a antibody
ab93538 has not yet been referenced specifically in any publications.